 |
|
|
|
28 January 2008 |
|
|
|
B-K Medical and Advanced Medical Diagnostics Collaborate on the Introduction of
HistoScanning Technology for the Prostate |
|
|
|
Urology ultrasound market leader and tissue characterization innovator introduce
new tools for the management of prostate patients. |
|
|
Copenhagen, Denmark and Waterloo, Belgium (January 28, 2008): B-K Medical,
a wholly owned subsidiary of Analogic Corporation (NASDAQ: ALOG), and Advanced Medical
Diagnostics, S.A., a company committed to providing innovative computer-aided solutions
that improve the diagnostic interpretation of ultrasound scans, today announced
the signing of a collaboration agreement under which they will deploy the innovative
HistoScanning™ tissue characterization technology for the prostate.
HistoScanning is a proprietary tissue differentiation, visualization and measurement
technology designed to assist specialists in identifying changes to solid organ
tissues. The technology works in conjunction with Transrectal Ultrasound (TRUS)
procedures and extracts new information from prostate ultrasound data. It adds an
important new dimension to the practice of prostate examination as well as prostate
biopsy indication and acquisition.
By entering into this collaboration, B-K Medical aims to retain and expand market
leadership by continuing to support and be at the forefront of the latest technological
advances in prostate ultrasound.
Michael Brock, B-K Medical's President, says, "We take our position as the innovators
in prostate ultrasound imaging seriously. We believe that being the market leader
reflects our commitment to identifying and developing the latest technological advances
for the good of our customers and their patients. HistoScanning has the potential
to be the major diagnostic modality of the future, increasing the efficiency and
diagnostic value of prostate ultrasound."
For Advanced Medical Diagnostics, the agreement facilitates introduction of its
technology to major global markets. Dror Nir, Chief Executive Officer of Advanced
Medical Diagnostics and inventor of the HistoScanning technology, points out, "We
want to make sure that HistoScanning will realize its potential. It means working
together with companies who share our vision of noninvasive tissue characterization
and are committed to investing in moving medicine forward." He went on to stress
that, "B-K is long recognized for its commitment to and leadership in urological
ultrasound, and it shares our view on how HistoScanning addresses the major clinical
challenges in prostate patient management."
The British Journal of
Urology recently published a study conducted on men whose
prostate biopsies tested positive and whose prostates were later surgically removed.
This study showed that in the study population, HistoScanning correctly identified
the largest tumors, accurately measured their diameters and correctly attributed
the presence of multiple foci, the laterality of the disease, and the involvement
of the prostate capsule.
Under the guidance of an international panel of clinical thought leaders, Advanced
Medical Diagnostics is supporting several multi-center studies in reference centers
across Europe to provide additional clinical evidence to validate the role of HistoScanning
in routine
clinical practice.
The first joint presentation of HistoScanning will be at the upcoming 23rd Annual
EAU (European Association of Urology) Congress in Milan, Italy, March 26-29, 2008.
HistoScanning for the prostate
is expected to be commercially introduced in Europe
later this year. |
|
|
|
Facts about B-K Medical |
|
|
B-K Medical ApS, a wholly owned subsidiary of Analogic Corporation (NASDAQ:
ALOG), specializes in the development and production of diagnostic ultrasound equipment.
The company is recognized as a world leader in developing ultrasound scanners specially
designed for surgery and for the investigation of urological disorders. The product
line also includes scanners for other applications, such as gynecological examinations,
fetal scanning, and radiology.
B-K Medical is represented in 60 countries, with subsidiary sales companies in the
U.S., Belgium, Germany, Italy, Norway, Sweden and the U.K. An extensive network
of distributors connects B-K Medical with Eastern Europe, the Middle East, Asia
and the rest of the world. The company has about 300 employees, of which about two-thirds
are located in Denmark. |
|
|
|
Facts about AMD |
|
|
Advanced Medical Diagnostics, S.A. is
a privately held company based in Waterloo, Belgium. The company is dedicated to improving
cancer diagnostics in a clinically meaningful and cost effective manner.
A dynamic and culturally diverse team of 20
experienced scientists, engineers and business professionals are committed to bringing
HistoScanning to medical specialists and their patients around the world.
HistoScanning™ is a trademark of Advanced Medical Diagnostics, S.A., Waterloo, Belgium. |
|
|
|
Contact: |
|
Jan Pieter Heemels |
Advanced Medical Diagnostics s.a.
Phone: +32 2 352 80 30
jheemels@histoscanning.com
http://www.histoscanning.com |
|
|
|
Steffen Jørgensen |
B-K Medical
World Headquarters
Mileparken 34, DK-2730 Herlev, Denmark
Tel: +45 4452 8100, Fax: +45 4452 8199
inquire@bkmed.com
http://www.bkmed.com |
|
|
